Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15017 total
VGK is telling two different stories at once: the price is rising while the cost to borrow is surging, creating a setup worth watching for anyone using this ETF as a European equity hedge. The ETF added 2.4% on the…
HUN just posted its worst single-day drop in recent memory, falling 17% on June 16 to close at $13.18 — and the short sellers who spent the past month quietly rebuilding positions were well positioned for it. Short…
Samsung Electronics has put in one of its strongest monthly runs in years, gaining 27% over the past month and 6.5% in the past week alone — yet its closest correlated peers spent the same week in reverse. The peer…
HSBC has added another 7.5% this week alone, closing at £14.096, and the question the market is now asking is whether the re-rating has moved fast enough to outrun the fundamentals. The valuation shift this week is the…
NOVO B clawed back 4% on the week to DKK 280.30, but the rebound sits inside a month that is still down 6.3% — and the stock's own scoring system keeps flashing a warning that short-term relief does not erase longer…
2330 closes the week at TWD 2,400, up 4.1% over five sessions, and the borrow story that dominated the last two notes has now reversed completely. The defining feature of this week is a dramatic unwind in domestic…
SoftBank Group heads into its June 24 earnings with a recovery story that short sellers are notably unwilling to challenge — a posture worth examining given what the last two prints delivered. The price recovery is the…
LATAM Airlines Group has put in a strong week, but the move looks more like a sector-wide lift than a company-specific catalyst. The stock gained 8.3% over the past week to close at CLP 24.49, extending a 13.7% rally…
GSK is the quiet outperformer in a difficult week for large-cap pharma — up 2.4% while most of its closest peers fell — and the question worth sitting with is whether that relative strength reflects genuine conviction…
LLOY has gained 6% in a week and 10.6% over the past month, joining a broad European banking rally — but the stock's own positioning data suggests the move is driven by genuine re-rating rather than short-covering…
NOKIA closed Tuesday at €12.01, down 4.2% on the day but barely changed on the week — a tentative pause in a correction that has now erased roughly 20% from the late-May peak, with peers falling in tandem and the…
Elevance Health gave back ground this week, falling 6.3% to $397.80 — erasing the gains that had briefly carried the stock above its consensus mean target and putting options traders on edge just four weeks before the…
Ormat Technologies enters the week with a fresh bearish analyst initiation landing on the same day options defensive positioning reaches its highest recorded level of the year. The standout event is Bernstein's…
CubeSmart's most interesting tension this week is a $4.6 million CEO share sale landing just as short interest accelerates — yet the analyst community is quietly lifting targets and borrow conditions remain…
FXI — the iShares China Large-Cap ETF — is sending contradictory signals this week: short sellers are adding positions again after a week of heavy covering, while options traders have turned more bullish than they have…
GOOGL has finally caught a bid — up 2.5% on the week to $373.25 — yet the gap between where the stock trades and what analysts think it's worth has barely shifted, keeping the same fundamental tension that has defined…
AngioDynamics heads into its July 13 quarterly print with shorts quietly unwinding and the Street holding a cautious optimism that the stock's 13% monthly rebound has yet to fully validate. The sharpest trend in…
Cytokinetics enters the back half of June with a stock up nearly 10% on the week and an options market that has decisively tilted toward call buyers — a combination that tells a cleaner bullish story than the short…
AIZ enters mid-June with a rare alignment: the stock is up 3.8% on the week, Morgan Stanley just upgraded it, and short sellers have quietly trimmed positions — leaving the picture notably cleaner than it looked a…
Arrowhead Pharmaceuticals enters the back half of June with short sellers quietly retreating and the Street turning more constructive — a combination that has helped the stock add 4.4% on the week to $76.55, even as it…
